EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Eisai Co's enterprise value is 円1,676,187 Mil.
Eisai Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円112,997 Mil. Therefore, Eisai Co's EV-to-EBITDA for today is 14.83.
The historical rank and industry rank for Eisai Co's EV-to-EBITDA or its related term are showing as below:
TSE:4523'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.27 Med: 5.3 Max: 61.28
Current: 14.83
During the past 13 years, the highest EV-to-EBITDA of Eisai Co was 61.28. The lowest was 2.27. And the median was 5.30.
TSE:4523's EV-to-EBITDA is ranked better than 53.39% of 708
companies
in the Drug Manufacturers industry
Industry Median: 14.075
vs TSE:4523: 14.83
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), Eisai Co's stock price is 円6259.00.
Eisai Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円168.380. Therefore, Eisai Co's PE Ratio for today is 37.17.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Eisai Co EV-to-EBITDA Historical Data
The historical data trend for Eisai Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eisai Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eisai Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Eisai Co's EV-to-EBITDA falls into.
Eisai Co EV-to-EBITDA Calculation
Eisai Co's EV-to-EBITDA for today is calculated as:
Eisai Co's current Enterprise Value is 円1,676,187 Mil.
Eisai Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円112,997 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eisai Co (TSE:4523) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Eisai Co's share price for today is 円6259.00.
Eisai Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円168.380.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Eisai Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4523 has been successfully added to your 